The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 30%.
ARK Innovation ETF ARKK
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $74.49
ARK Innovation ETF holds its Markdown at $74.49.
- PHPhase · the trend structure carries the Markdown label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · screen not yet scored
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 262 days |
| Price | $74.49 |
| Valuation | 0.00 trailing · 0.00 forward price to earnings |
| Values screen | Not scored |
| Beta | N/A |
The opportunity · what the numbers say it is worth
Our framework reads AVOID
Price history & projections · where it has been, where the models see it going
| Revenue growth | 0.00% |
| Profit margin | 0.00% |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This security has not been fully scored against the values screen yet.
- Business activity Thematic ETF — holdings require individual screening Fail
- Receivables Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Why it gives us pause
On our numbers, the price already runs ahead of the business.
| Forward P/E | 0.0x |
| Trailing P/E | 0.0x |
| Revenue growth | 0.0% revenue is shrinking |
| Profit margin | 0.0% currently unprofitable |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & how to trade · wherever in the world you are
ARKK trades on NYSE ARCA. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 30%.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 30%.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $80.03 | -8.0% | · | $920 | -8.0% |
| 2 months | $69.29 | +6.3% | · | $1,063 | +6.3% |
| 3 months | $70.64 | +4.2% | · | $1,042 | +4.2% |
| 6 months | $82.06 | -10.3% | · | $897 | -10.3% |
| 1 year | $62.94 | +17.0% | · | $1,170 | +17.0% |
| 2 years | $44.15 | +66.8% | · | $1,668 | +66.8% |
| 3 years | $42.16 | +74.7% | $0.36 | $1,755 | +75.5% |
| 5 years | $114.22 | -35.5% | $1.15 | $655 | -34.5% |
Historical returns from market close data. Past performance does not guarantee future results.